These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 9586944)

  • 1. An assessment of drug-haematin binding as a mechanism for inhibition of haematin polymerisation by quinoline antimalarials.
    Dorn A; Vippagunta SR; Matile H; Jaquet C; Vennerstrom JL; Ridley RG
    Biochem Pharmacol; 1998 Mar; 55(6):727-36. PubMed ID: 9586944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison and analysis of several ways to promote haematin (haem) polymerisation and an assessment of its initiation in vitro.
    Dorn A; Vippagunta SR; Matile H; Bubendorf A; Vennerstrom JL; Ridley RG
    Biochem Pharmacol; 1998 Mar; 55(6):737-47. PubMed ID: 9586945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Haematin (haem) polymerization and its inhibition by quinoline antimalarials.
    Ridley RG; Dorn A; Vippagunta SR; Vennerstrom JL
    Ann Trop Med Parasitol; 1997 Jul; 91(5):559-66. PubMed ID: 9329993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of LAR and VAR on Para-Aminopyridine Antimalarials Targetting Haematin in Chloroquine-Resistance.
    Warhurst DC; Craig JC; Raheem KS
    PLoS One; 2016; 11(8):e0160091. PubMed ID: 27483471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural specificity of chloroquine-hematin binding related to inhibition of hematin polymerization and parasite growth.
    Vippagunta SR; Dorn A; Matile H; Bhattacharjee AK; Karle JM; Ellis WY; Ridley RG; Vennerstrom JL
    J Med Chem; 1999 Nov; 42(22):4630-9. PubMed ID: 10579825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel phenothiazine antimalarials: synthesis, antimalarial activity, and inhibition of the formation of beta-haematin.
    Kalkanidis M; Klonis N; Tilley L; Deady LW
    Biochem Pharmacol; 2002 Mar; 63(5):833-42. PubMed ID: 11911834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of chloroquine and its analogues with heme: An isothermal titration calorimetric study.
    Bachhawat K; Thomas CJ; Surolia N; Surolia A
    Biochem Biophys Res Commun; 2000 Oct; 276(3):1075-9. PubMed ID: 11027592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. On the molecular mechanism of chloroquine's antimalarial action.
    Sullivan DJ; Gluzman IY; Russell DG; Goldberg DE
    Proc Natl Acad Sci U S A; 1996 Oct; 93(21):11865-70. PubMed ID: 8876229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deferoxamine: stimulation of hematin polymerization and antagonism of its inhibition by chloroquine.
    Vippagunta SR; Dorn A; Bubendorf A; Ridley RG; Vennerstrom JL
    Biochem Pharmacol; 1999 Sep; 58(5):817-24. PubMed ID: 10449192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-iron porphyrins inhibit beta-haematin (malaria pigment) polymerisation.
    Basilico N; Monti D; Olliaro P; Taramelli D
    FEBS Lett; 1997 Jun; 409(2):297-9. PubMed ID: 9202165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thermodynamic factors controlling the interaction of quinoline antimalarial drugs with ferriprotoporphyrin IX.
    Egan TJ; Mavuso WW; Ross DC; Marques HM
    J Inorg Biochem; 1997 Nov; 68(2):137-45. PubMed ID: 9336973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, β-haematin inhibition, and in vitro antimalarial testing of isocryptolepine analogues: SAR study of indolo[3,2-c]quinolines with various substituents at C2, C6, and N11.
    Wang N; Wicht KJ; Imai K; Wang MQ; Anh Ngoc T; Kiguchi R; Kaiser M; Egan TJ; Inokuchi T
    Bioorg Med Chem; 2014 May; 22(9):2629-42. PubMed ID: 24721829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activity of piperaquine and other 4-aminoquinoline antiplasmodial drugs against chloroquine-sensitive and resistant blood-stages of Plasmodium falciparum. Role of beta-haematin inhibition and drug concentration in vacuolar water- and lipid-phases.
    Warhurst DC; Craig JC; Adagu IS; Guy RK; Madrid PB; Fivelman QL
    Biochem Pharmacol; 2007 Jun; 73(12):1910-26. PubMed ID: 17466277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bayesian models trained with HTS data for predicting β-haematin inhibition and in vitro antimalarial activity.
    Wicht KJ; Combrinck JM; Smith PJ; Egan TJ
    Bioorg Med Chem; 2015 Aug; 23(16):5210-7. PubMed ID: 25573118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro antimalarial activity, β-haematin inhibition and structure-activity relationships in a series of quinoline triazoles.
    Joshi MC; Wicht KJ; Taylor D; Hunter R; Smith PJ; Egan TJ
    Eur J Med Chem; 2013 Nov; 69():338-47. PubMed ID: 24077524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Affinity of antimalarial drugs for stacked haematin linked on sepharose.
    Moreau S; Charet P; Prensier G
    Ann Trop Med Parasitol; 1986 Apr; 80(2):169-76. PubMed ID: 3753061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in anti-malarial activity of 4-aminoalcohol quinoline enantiomers and investigation of the presumed underlying mechanism of action.
    Mullié C; Jonet A; Desgrouas C; Taudon N; Sonnet P
    Malar J; 2012 Mar; 11():65. PubMed ID: 22401346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Docking, synthesis and antimalarial activity of novel 4-anilinoquinoline derivatives.
    Vijayaraghavan S; Mahajan S
    Bioorg Med Chem Lett; 2017 Apr; 27(8):1693-1697. PubMed ID: 28318947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lapatinib, Nilotinib and Lomitapide Inhibit Haemozoin Formation in Malaria Parasites.
    de Sousa ACC; Maepa K; Combrinck JM; Egan TJ
    Molecules; 2020 Mar; 25(7):. PubMed ID: 32235391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quinoline anti-malarial drugs inhibit spontaneous formation of beta-haematin (malaria pigment).
    Egan TJ; Ross DC; Adams PA
    FEBS Lett; 1994 Sep; 352(1):54-7. PubMed ID: 7925942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.